Recombinant Phe-Free Proteins for PKU Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for phenylketonuria (PKU) are limited by the unpleasant taste and smell of medical food proteins, leading to compliance issues, and are costly, particularly enzyme replacement therapies which require high-dose cofactors like BH4 or large doses of phenylalanine ammonia-lyase (PAL).
Innovation Solution
Development of recombinant phenylalanine-free proteins with optimized amino acid compositions, produced using GRAS expression systems like Bacillus subtilis and Bacillus licheniformis, which are more palatable, cost-effective, and can be incorporated into food products, replacing traditional amino acid-based formulas.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional amino acid-based medical food formulas are used to treat PKU, then the treatment provides necessary protein intake, but the unpleasant taste and smell lead to poor patient compliance
Solution Approach 1:
The invention changes the chemical composition parameters by using recombinant proteins with specifically modified amino acid sequences that exclude phenylalanine and reduce problematic metabolites, while maintaining essential amino acid profiles. This transforms the sensory properties (taste and smell) without sacrificing nutritional value, thereby improving patient compliance
Solution Approach 2:
The invention creates composite protein formulations by combining multiple recombinant proteins with complementary amino acid profiles. These composite materials provide complete protein nutrition while distributing the sensory properties across multiple components, reducing overall unpleasant taste and smell compared to single amino acid formulas
2Reliability
If enzyme replacement therapy with PAL or high-dose BH4 is used to treat PKU, then phenylalanine metabolism is improved, but the treatment cost increases significantly
Solution Approach 1:
The invention uses cost-effective recombinant protein products that can be produced at scale through efficient expression systems. These proteins serve as a affordable, renewable resource that replaces expensive enzyme therapies, providing sustained phenylalanine metabolism control without the high recurring costs of enzyme replacement or high-dose cofactor supplementation
Solution Approach 2:
The recombinant proteins are designed to work with the patient's endogenous metabolic pathways, enabling self-regulation of phenylalanine metabolism without requiring external enzyme administration or high-dose cofactors. The proteins provide structural and functional support that allows the body's own metabolic machinery to function properly, reducing dependency on expensive therapeutic interventions
3Reliability
If strict Phe-restricted diet is maintained to manage PKU, then phenylalanine accumulation is prevented, but compliance decreases as subjects age due to lifestyle restrictions
Solution Approach 1:
The recombinant proteins serve multiple functions: they provide essential amino acids for protein synthesis, support phenylalanine metabolism, and enable greater dietary flexibility. This multi-functionality allows patients to maintain phenylalanine level control while enjoying a more varied and socially acceptable diet, improving ease of operation as they age
Solution Approach 2:
The invention changes the nutritional parameters by providing complete protein formulations with optimized amino acid profiles that reduce phenylalanine burden. This allows patients to transition from strict phenylalanine restriction to a more flexible diet that includes natural foods, improving lifestyle flexibility without compromising phenylalanine level control
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The recombinant proteins improve patient compliance and reduce treatment costs by providing a palatable, phenylalanine-free alternative that can be used in various food products, allowing for a more manageable and affordable PKU diet.
Implementation Method 1
recombinant Phe-free proteins according to the invention may be made by a method comprising i) cultivating a recombinant host cell of the present invention under conditions conductive for production of the protein, and ii) recovering the protein
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to a method for preparing a recombinant Phe-free or Phe- low protein, the method comprising using B.subtilis or B. licheniformis as an expression system and/or a recombinant host cell into which a nucleotide encoding a recombinant Phe-free or Phe-low protein has been inserted into the genome.